CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors

Therapy resistance is a significant concern while treating malignant disease. Accumulating evidence suggests that a subset of cancer cells potentiates tumor survival, therapy resistance, and relapse. Several different pathways regulate these purported cancer stem cells (CSCs). Evidence shows that th...

Descripción completa

Detalles Bibliográficos
Autores principales: Molczyk, Caitlin, Singh, Rakesh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953306/
https://www.ncbi.nlm.nih.gov/pubmed/36831112
http://dx.doi.org/10.3390/biomedicines11020576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953306/
https://www.ncbi.nlm.nih.gov/pubmed/36831112
http://dx.doi.org/10.3390/biomedicines11020576

Ejemplares similares